General information, not an individual diagnosis. Ask a healthcare professional if you are unsure about your situation.
A change in vision during PLAQUENIL treatment requires immediate medical contact. Its prescribing information requires stopping the medicine and careful monitoring.
Retinal damage may cause no symptoms. Having no visual discomfort therefore does not replace the planned eye checks.
An eye assessment may be prescribed before prolonged treatment. For lupus, Ameli describes an initial examination of the eye’s fundus.
For lupus, Ameli notes low but cumulative retinal toxicity. Regular ophthalmological monitoring accompanies hydroxychloroquine treatment.
Retinal damage can progress after the medicine is stopped. Eye follow-up remains necessary when an abnormality has been detected.
If the planned examination requires pupil dilation, arrange an accompanied return or public transport. Glare can make driving difficult for several hours.
Sources
- BDPM/ANSM — PLAQUENIL 200 mg : vision et suivi rétinien, notice et RCP du 17 août 2026
- Assurance Maladie — Traitement du lupus : hydroxychloroquine et surveillance des yeux, article du 7 septembre 2026
- Assurance Maladie — Comment se déroule un fond d’œil ? Préparation et retour, article du 26 janvier 2026
Your health review
Review your health
Mon bilan prévention is an appointment to discuss your habits and choose your health priorities. Review the four age groups and practical information.